Context Therapeutics Inc. Company Profile
NASDAQ: CNTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
After hours: 0.3038 -0.13%
Context Therapeutics at a glance
Context Therapeutics Inc. (NASDAQ: CNTX) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Philadelphia, PA. Context Therapeutics is led by Mr. Martin A. Lehr and employs about 15 people. The company's shares have traded publicly since 2021.
At a market capitalization of $27.5 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001842952, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Context Therapeutics do?
Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of solid tumors. The company's product candidate includes CTIM-76, a Claudin 6 (CLDN6) x CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. It has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of a CLDN6 bispecific monoclonal antibody for cancer therapy. The company was incorporated in 2015 and is headquartered in Philadelphia, Pennsylvania.
Business description based on the company's public filings.
Company information
- Legal name
- Context Therapeutics Inc.
- Ticker
- NASDAQ: CNTX
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. Martin A. Lehr
- Employees
- 15
- Headquarters
- 2001 Market Street, Philadelphia, PA, United States
- Phone
- 267 225 7416
- Website
- contexttherapeutics.com
- IPO year
- 2021
- Market cap
- $27.47M
- SEC CIK
- 0001842952
Companies similar to Context Therapeutics
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| MCRBSeres Therapeutics Inc. | 2.71 | +3.04% | $27.22M | vs CNTX |
| IMMPImmutep Limited ADR | 3.63 | -5.47% | $26.75M | vs CNTX |
| ABVCABVC BioPharma Inc. | 1.00 | +2.04% | $26.69M | vs CNTX |
| IGCIGC Pharma Inc. | 0.2799 | -1.75% | $28.94M | vs CNTX |
| SHPHShuttle Pharmaceuticals Holdings Inc. | 5.33 | -4.05% | $25.40M | vs CNTX |
| BYSIBeyondSpring Inc. | 0.6056 | -0.56% | $24.90M | vs CNTX |
| KYNBKyntra Bio Inc. | 6.11 | +2.52% | $24.74M | vs CNTX |
| ATOSAtossa Therapeutics Inc. | 2.44 | +0.83% | $24.35M | vs CNTX |